Contraception

Latest News

Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive  | Image Credit: © JPC-PROD - © JPC-PROD - stock.adobe.com.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive

December 5th 2023

Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.

Disparities in reproductive health services for women with disabilities | Image Credit: © Jo Panuwat D - © Jo Panuwat D - stock.adobe.com.
Disparities in reproductive health services for women with disabilities

December 1st 2023

Contemporary OB/GYN week in review: maternal vaccination, intrapartum fever, and more
Contemporary OB/GYN week in review: maternal vaccination, intrapartum fever, and more

November 17th 2023

Smart Women’s Choice faces federal court order to halt unlawful contraceptive distribution | Image Credit: © WESTOCK - © WESTOCK - stock.adobe.com.
Smart Women’s Choice faces federal court order to halt unlawful contraceptive distribution

November 16th 2023

Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives | Image Credit: © Jo Panuwat D - © Jo Panuwat D - stock.adobe.com.
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives

November 8th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.